search innovation

The subject of the offer is a new medical device intended for a wide range of applications in the reconstruction of the conductive apparatus of the middle ear ossicles.

Application: implantation to replace damaged or destroyed elements in the middle ear's conducting chain

 

Hearing impairment is a major problem for patients with middle ear disorders. One of the most common causes of this dysfunction is chronic otitis media. Many of these cases involve damage or even destruction of the middle ear’s conductive chain and require surgical intervention. The standard method of treatment is middle ear implants. Their limitation, however, is the limited scope of potential application. This leads to the emergence of significant logistical problems forcing the possession of many expensive models of prostheses by units performing the implantation of auditory implants. So far, in the field of middle ear surgery, there are no solutions that allow matching one reconstruction system to different types of damage, which are often diagnosed only during surgery.

The proposed prosthesis, which may be used in surgical treatment of middle ear pathology, has the possibility of individual adjustment, allowing for effective hearing improvement in various types of damage. The new system is characterized by a simple construction based on a single element and allows for the partial or complete replacement of the damaged ossicular chain.

 

Advantages of the new prosthesis:

- high sound wave transmission efficiency

- safety of use

- functionality and intraoperative ease of modeling

- the universality of use in various clinical conditions

- low production cost.

 

The invention has successfully passed preclinical tests and is currently in clinical development. The prosthesis was implanted in a group of patients in whom its effectiveness and safety were demonstrated. The offered solution is the subject of a patent application. Further works aimed at implementing the invention is carried out by scientists from the Collegium Medicum of the Jagiellonian University and the AGH University of Science and Technology in Kraków. Currently, the Centre for Technology Transfer CITTRU is looking for entities interested in commercial use of the described solution.

logotypy projektu Inkubator Innowacyjnosci+, Fundusze Europejskie, Unia Europejska, MNiSW

field of science: medicine
forms of protection: patent application
technological maturity: tests - clinical trials
property rights: co-ownership
variants of cooperation: spin-off company, sale

information / broker of Jagiellonian University

name and surname: Magdalena Kulczycka
phone number: +48 12 664 42 09, + 48 506 006 761
NEWS
latest information
Big Pharma Day online
Big Pharma Day online is an industry meeting on the development of drug projects, organized by CTT CITTRU, happening on March 25, 2021. The event will include expert presentations and individual meetings.
A new, effective method for obtaining common ash cuttings
Discover a new technology for obtaining cuttings of common ash developed by the interdisciplinary research team from the Jagiellonian University and the University of Agriculture in Krakow.
Development of biotization technology for commercial and ecological production of berry fruits
The scientific team from Jagiellonian University developed an inoculum that stimulates seedling growth.
CITTRU team
Our employees
PARTNERS
Innovation Forum KrakówKlaster Lifescience KrakówWolves SummitPACTTJagiellońskie Centrum Innowacji
Contact
GET IN TOUCH WITH US
Centre for Technology Transfer CITTRU
Jagiellonian University in Kraków - POLAND
ul. Bobrzyńskiego 14,
30-348 Kraków

PHONE:
+48 12 664 42 00
E-MAIL:
cittru@uj.edu.pl
Fundusze EuropejskieMNiSWInkubator InnowacyjnościUnia Europejska